Mesenchymal stem cell-derived extracellular vesicles promote angiogenesis: Potencial clinical application

Frontiers in Physiology

Volumn 7, Issue FEB, 2016, Pages

  Merino González, Consuelo ^a   Zuñiga, Felipe A ^a   Escudero, Carlos ^b,c   Ormazabal, Valeska ^a   Reyes, Camila ^a   Nova Lamperti, Estefanía ^d   Salomón, Carlos ^e   Aguayo, Claudio ^a,c  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

^b UNIVERSIDAD DEL BÍO BÍO   (Chile)

^c Group of Research and Innovation in Vascular Health (GRIVAS Health)   (Chile)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Angiogenesis; Extracellular vesicles; Mesenchymal stem cell

Indexed keywords

ADIPOCYTE; ADULT; ANGIOGENESIS; CARTILAGE CELL; CELL DIFFERENTIATION; EXOSOME; MESENCHYMAL STEM CELL; MULTIPOTENT STEM CELL; OSTEOCYTE; SOLUBILITY; TISSUE REGENERATION;

EID: 84962683835     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2016.00024     Document Type: Short Survey

References (95)

1. Adams, R. H., and Alitalo, K. (2007). Molecular regulation of angiogenesis and lymphangiogenesis. Nat. Rev. Mol. Cell Biol. 8, 464-478. doi: 10.1038/nrm2183.
2. Aguilera, V., Briceño, L., Contreras, H., Lamperti, L., Sepúlveda, E., Díaz-Perez, F., et al. (2014). Endothelium trans differentiated from Wharton's jelly mesenchymal cells promote tissue regeneration: potential role of soluble pro-angiogenic factors. PLoS ONE 9:e111025. doi: 10.1371/journal.pone.0111025.
3. Alderton, G. K. (2012). Metastasis: Exosomes drive premetastatic niche formation. Nat. Rev. Cancer 12, 447-447. doi: 10.1038/nrc3304.
4. Alviano, F., Fossati, V., Marchionni, C., Arpinati, M., Bonsi, L., Franchina, M., et al. (2007). Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev. Biol. 7:11. doi: 10.1186/1471-213X-7-11.
5. Baglio, S. R., Rooijers, K., Koppers-Lalic, D., Verweij, F. J., Lanzón, M. P., Zini, N., et al. (2015). Human bone marrow-and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive miRNA and tRNA species. Stem Cell Res. Ther. 6, 1-20. doi: 10.1186/s13287-015-0116-z.
6. Battula, V. L., Bareiss, P. M., Treml, S., Conrad, S., Albert, I., Hojak, S., et al. (2007). Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 75, 279-291. doi: 10.1111/j.1432-0436.2006.00139.x.
7. Bazigou, E., and Makinen, T. (2013). Flow control in our vessels: vascular valves make sure there is no way back. Cell. Mol. Life Sci. 70, 1055-1066. doi: 10.1007/s00018-012-1110-6.
8. Bruno, S., Grange, C., Collino, F., Deregibus, M. C., Cantaluppi, V., Biancone, L., et al. (2012). Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS ONE 7:e33115. doi: 10.1371/journal.pone.0033115.
9. Camussi, G., Deregibus, M. C., Bruno, S., Cantaluppi, V., and Biancone, L. (2010). Exosomes/microvesicles as a mechanism of cell-to-cell communication. Kidney Int. 78, 838-848. doi: 10.1038/ki.2010.278.
10. Cantaluppi, V., Biancone, L., Figliolini, F., Beltramo, S., Medica, D., Deregibus, M. C., et al. (2012). Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets. Cell Transplant. 21, 1305-1320. doi: 10.3727/096368911X627534.
11. Cao, H., Qian, H., Xu, W., Zhu, W., Zhang, X., Chen, Y., et al. (2010). Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusion-induced acute renal failure in rats. Biotechnol. Lett. 32, 725-732. doi: 10.1007/s10529-010-0207-y.
12. Caplan, A. I. (1991). Mesenchymal stem cells. J. Orthop. Res. 9, 641-650. doi: 10.1002/jor.1100090504.
13. Caplan, A. I., and Dennis, J. E. (2006). Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98, 1076-1084. doi: 10.1002/jcb.20886.
14. Carceller, M. C., Guillén, M. I., Ferrándiz, M. L., and Alcaraz, M. J. (2015). Paracrine in vivo inhibitory effects of adipose tissue-derived mesenchymal stromal cells in the early stages of the acute inflammatory response. Cytotherapy 17, 1230-1239. doi: 10.1016/j.jcyt.2015.06.001.
15. Chade, A. R., and Stewart, N. (2013). Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use? J. Am. Soc. Hypertens. 7, 180-190. doi: 10.1016/j.jash.2013.01.004.
16. Chen, T. S., Lai, R. C., Lee, M. M., Choo, A. B. H., Lee, C. N., and Lim, S. K. (2010). Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res. 38, 215-224. doi: 10.1093/nar/gkp857.
17. Colombo, M., Raposo, G., and Théry, C. (2014). Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu. Rev. Cell Dev. Biol. 30, 255-289. doi: 10.1146/annurev-cellbio-101512-122326.
18. Copelan, E. A. (2006). Hematopoietic stem-cell transplantation. New Engl. J. Med. 354, 1813-1826. doi: 10.1056/NEJMra052638.
19. Coultas, L., Chawengsaksophak, K., and Rossant, J. (2005). Endothelial cells and VEGF in vascular development. Nature 438, 937-945. doi: 10.1038/nature04479.
20. Dariolli, R., Bassaneze, V., Nakamuta, J. S., Omae, S. V., Campos, L. C. G., and Krieger, J. E. (2013). Porcine adipose tissue-derived mesenchymal stem cells retain their proliferative characteristics, senescence, karyotype and plasticity after long-term cryopreservation. PLoS ONE 8:e67939. doi: 10.1371/journal.pone.0067939.
21. Da Silva Meirelles, L., Fontes, A. M., Covas, D. T., and Caplan, A. I. (2009). Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 20, 419-427. doi: 10.1016/j.cytogfr.2009.10.002.
22. Deregibus, M. C., Cantaluppi, V., Calogero, R., Iacono, M. L., Tetta, C., Biancone, L., et al. (2007). Endothelial progenitor cell-derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 110, 2440-2448. doi: 10.1182/blood-2007-03-078709.
23. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8, 315-317. doi: 10.1080/14653240600855905.
24. English, K. (2013). Mechanisms of mesenchymal stromal cell immunomodulation. Immunol. Cell Biol. 91, 19-26. doi: 10.1038/icb.2012.56.
25. Friedenstein, A. J., Chailakhyan, R. K., Latsinik, N. V., Panasyuk, A. F., and Keiliss-Borok, I. V. (1974). Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: cloning in vitro and retransplantation in vivo. Transplantation 17, 331-340. doi: 10.1097/00007890-197404000-00001.
26. Galderisi, U., and Giordano, A. (2014). The gap between the physiological and therapeutic roles of mesenchymal stem cells. Med. Res. Rev. 34, 1100-1126. doi: 10.1002/med.21322.
27. Gross, J. C., Chaudhary, V., Bartscherer, K., and Boutros, M. (2012). Active Wnt proteins are secreted on exosomes. Nat. Cell Biol. 14, 1036-1045. doi: 10.1038/ncb2574.
28. He, J., Wang, Y., Sun, S., Yu, M., Wang, C., Pei, X., et al. (2012). Bone marrow stem cells-derived microvesicles protect against renal injury in the mouse remnant kidney model. Nephrology 17, 493-500. doi: 10.1111/j.1440-1797.2012.01589.x.
29. Higginbotham, J. N., Demory Beckler, M., Gephart, J. D., Franklin, J. L., Bogatcheva, G., Kremers, G.-J., et al. (2011). Amphiregulin exosomes increase cancer cell invasion. Curr. Biol. 21, 779-786. doi: 10.1016/j.cub.2011.03.043.
30. Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., and De Bruijn, E. A. (2004). Vascular endothelial growth factor and angiogenesis. Pharmacol. Rev. 56, 549-580. doi: 10.1124/pr.56.4.3.
31. Huang, L., Ma, W., Ma, Y., Feng, D., Chen, H., and Cai, B. (2015). Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases? Int. J. Biol. Sci. 11, 238-245. doi: 10.7150/ijbs.10725.
32. Hunkapiller, J., Shen, Y., Diaz, A., Cagney, G., McCleary, D., Ramalho-Santos, M., et al. (2012). Polycomb-like 3 promotes polycomb repressive complex 2 binding to CpG islands and embryonic stem cell self-renewal. PLoS Genet. 8:e1002576. doi: 10.1371/journal.pgen.1002576.
33. Kahlert, C., and Kalluri, R. (2013). Exosomes in tumor microenvironment influence cancer progression and metastasis. J. Mol. Med. 91, 431-437. doi: 10.1007/s00109-013-1020-6.
34. Kang, K., Ma, R., Cai, W., Huang, W., Paul, C., Liang, J., et al. (2015). Exosomes secreted from CXCR4 overexpressing mesenchymal stem cells promote cardioprotection via akt signaling pathway following myocardial infarction. Stem Cells Int. 2015:659890. doi: 10.1155/2015/659890.
35. Kastelowitz, N., and Yin, H. (2014). Exosomes and microvesicles: identification and targeting by particle size and lipid chemical probes. Chembiochem 15, 923-928. doi: 10.1002/cbic.201400043.
36. Khan, M., Ali, F., Mohsin, S., Akhtar, S., Mehmood, A., Choudhery, M. S., et al. (2013). Preconditioning diabetic mesenchymal stem cells with myogenic medium increases their ability to repair diabetic heart. Stem Cell Res. Ther. 4, 58-71. doi: 10.1186/scrt207.
37. Khubutiya, M. S., Vagabov, A. V., Temnov, A. A., and Sklifas, A. N. (2014). Paracrine mechanisms of proliferative, anti-apoptotic and anti-inflammatory effects of mesenchymal stromal cells in models of acute organ injury. Cytotherapy 16, 579-585. doi: 10.1016/j.jcyt.2013.07.017.
38. Kim, H.-S., Choi, D.-Y., Yun, S. J., Choi, S.-M., Kang, J. W., Jung, J. W., et al. (2011). Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J. Proteome Res. 11, 839-849. doi: 10.1021/pr200682z.
39. Kinnaird, T., Stabile, E., Burnett, M., Lee, C., Barr, S., Fuchs, S., et al. (2004a). Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94, 678-685. doi: 10.1161/01.RES.0000118601.37875.AC.
40. Kinnaird, T., Stabile, E., Burnett, M., Shou, M., Lee, C., Barr, S., et al. (2004b). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109, 1543-1549. doi: 10.1161/01.CIR.0000124062.31102.57.
41. Kitagawa, M., Hojo, M., Imayoshi, I., Goto, M., Ando, M., Ohtsuka, T., et al. (2013). Hes1 and Hes5 regulate vascular remodeling and arterial specification of endothelial cells in brain vascular development. Mech. Dev. 130, 458-466. doi: 10.1016/j.mod.2013.07.001.
42. Lai, R. C., Arslan, F., Lee, M. M., Sze, N. S. K., Choo, A., Chen, T. S., et al. (2010). Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 4, 214-222. doi: 10.1016/j.scr.2009.12.003.
43. Lai, R. C., Tan, S. S., Teh, B. J., Sze, S. K., Arslan, F., De Kleijn, D. P., et al. (2012). Proteolytic potential of the MSC exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome. Int. J. Proteomics 2012:971907. doi: 10.1155/2012/971907.
44. Lai, R. C., Yeo, R. W., and Limm, S. K. (2015). Mesenchymal stem cell exosomes. Semin. Cell Dev. Biol. 40, 82-88. doi: 10.1016/j.semcdb.2015.03.001.
45. Lakkaraju, A., and Rodriguez-Boulan, E. (2008). Itinerant exosomes: emerging roles in cell and tissue polarity. Trends Cell Biol. 18, 199-209. doi: 10.1016/j.tcb.2008.03.002.
46. Laroni, A., Novi, G., de Rosbo, N. K., and Uccelli, A. (2013). Towards clinical application of mesenchymal stem cells for treatment of neurological diseases of the central nervous system. J. Neuroimmune Pharmacol. 8, 1062-1076. doi: 10.1007/s11481-013-9456-6.
47. Lee, C., Mitsialis, S. A., Aslam, M., Vitali, S. H., Vergadi, E., Konstantinou, G., et al. (2012). Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 126, 2601-2611. doi: 10.1161/CIRCULATIONAHA.112.114173.
48. Lee, J.-K., Park, S.-R., Jung, B.-K., Jeon, Y.-K., Lee, Y.-S., Kim, M.-K., et al. (2013). Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS ONE 8:e84256. doi: 10.1371/journal.pone.0084256.
49. Li, C., Li, G., Liu, M., Zhou, T., and Zhou, H. (2015). Paracrine effect of inflammatory cytokine-activated bone marrow mesenchymal stem cells and its role in osteoblast function. J. Biosci. Bioeng. 121, 213-219. doi: 10.1016/j.jbiosc.2015.05.017.
50. Li, Q., and Lozano, G. (2013). Molecular pathways: targeting Mdm2 and Mdm4 in cancer therapy. Clin. Cancer Res. 19, 34-41. doi: 10.1158/1078-0432.CCR-12-0053.
51. Li, T., Yan, Y., Wang, B., Qian, H., Zhang, X., Shen, L., et al. (2012). Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 22, 845-854. doi: 10.1089/scd.2012.0395.
52. Liang, X., Ding, Y., Zhang, Y., Tse, H. F., and Lian, Q. (2014). Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant. 23, 1045-1059. doi: 10.3727/096368913X667709.
53. Lopatina, T., Bruno, S., Tetta, C., Kalinina, N., Porta, M., and Camussi, G. (2014). Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun. Signal. 12, 26. doi: 10.1186/1478-811X-12-26.
54. Lu, R., Qu, Y., Ge, J., Zhang, L., Su, Z., Pflugfelder, S. C., et al. (2012). Transcription factor TCF4 maintains the properties of human corneal epithelial stem cells. Stem Cells 30, 753-761. doi: 10.1002/stem.1032.
55. Majore, I., Moretti, P., Stahl, F., Hass, R., and Kasper, C. (2011). Growth and differentiation properties of mesenchymal stromal cell populations derived from whole human umbilical cord. Stem Cell Rev. 7, 17-31. doi: 10.1007/s12015-010-9165-y.
56. Maruotti, N., Corrado, A., Neve, A., and Cantatore, F. P. (2013). Systemic effects of Wnt signaling. J. Cell. Physiol. 228, 1428-1432. doi: 10.1002/jcp.24326.
57. Mathivanan, S., Ji, H., and Simpson, R. J. (2010). Exosomes: extracellular organelles important in intercellular communication. J. Proteomics 73, 1907-1920. doi: 10.1016/j.jprot.2010.06.006.
58. Mimeault, M., and Batra, S. K. (2012). Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies. Adv. Exp. Med. Biol. 741, 171-186. doi: 10.1007/978-1-4614-2098-9_12.
59. Mitrano, T. I., Grob, M. S., Carrion, F., Nova-Lamperti, E., Luz, P. A., Fierro, F. S., et al. (2010). Culture and characterization of mesenchymal stem cells from human gingival tissue. J. Periodontol. 81, 917-925. doi: 10.1902/jop.2010.090566.
60. Molina, E. R., Smith, B. T., Shah, S. R., Shin, H., and Mikos, A. G. (2015). Immunomodulatory properties of stem cells and bioactive molecules for tissue engineering. J. Control Release 219, 107-118. doi: 10.1016/j.jconrel.2015.08.038.
61. Morishita, R., Nakamura, S., Hayashi, S.-I., Taniyama, Y., Moriguchi, A., Nagano, T., et al. (1999). Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy. Hypertension 33, 1379-1384. doi: 10.1161/01.HYP.33.6.1379.
62. Nagpal, N., and Kulshreshtha, R. (2014). miR-191: an emerging player in disease biology. Front. Genet. 5:99. doi: 10.3389/fgene.2014.00099.
63. Nakamura, Y., Miyaki, S., Ishitobi, H., Matsuyama, S., Nakasa, T., Kamei, N., et al. (2015). Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration. FEBS Lett. 589, 1257-1265. doi: 10.1016/j.febslet.2015.03.031.
64. Olsson, A.-K., Dimberg, A., Kreuger, J., and Claesson-Welsh, L. (2006). VEGF receptor signalling? In control of vascular function. Nat. Rev. Mol. Cell Biol. 7, 359-371. doi: 10.1038/nrm1911.
65. Parolini, O., Alviano, F., Bagnara, G. P., Bilic, G., Bühring, H. J., Evangelista, M., et al. (2008). Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26, 300-311. doi: 10.1634/stemcells.2007-0594.
66. Pate, K. T., Stringari, C., Sprowl-Tanio, S., Wang, K., TeSlaa, T., Hoverter, N. P., et al. (2014). Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer. EMBO J. 33, 1454-1473. doi: 10.15252/embj.201488598.
67. Patel, A. N., Vargas, V., Revello, P., and Bull, D. A. (2013). Mesenchymal stem cell population isolated from the subepithelial layer of umbilical cord tissue. Cell Transplant. 22, 513-519. doi: 10.3727/096368912X655064.
68. Plock, J. A., Schnider, J. T., Zhang, W., Schweizer, R., Tsuji, W., Kostereva, N., et al. (2015). Adipose-and bone marrow-derived mesenchymal stem cells prolong graft survival in vascularized composite allotransplantation. Transplantation 99, 1765-1773. doi: 10.1097/TP.0000000000000731.
69. Rani, S., Ryan, A. E., Griffin, M. D., and Ritter, T. (2015). Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications. Mol. Ther. 23, 812-823. doi: 10.1038/mt.2015.44.
70. Reis, M., and Liebner, S. (2013). Wnt signaling in the vasculature. Exp. Cell Res. 319, 1317-1323. doi: 10.1016/j.yexcr.2012.12.023.
71. Salomon, C., Kobayashi, M., Ashman, K., Sobrevia, L., Mitchell, M. D., and Rice, G. E. (2013). Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes. PLoS ONE. 8:e79636. doi: 10.1371/journal.pone.0079636.
72. Salvolini, E., Lucarini, G., Zizzi, A., Orciani, M., Di Benedetto, G., and Di Primio, R. (2010). Human skin-derived mesenchymal stem cells as a source of VEGF and nitric oxide. Arch. Dermatol. Res. 302, 367-374. doi: 10.1007/s00403-009-1018-7.
73. Shih, T., and Lindley, C. (2006). Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin. Ther. 28, 1779-1802. doi: 10.1016/j.clinthera.2006.11.015.
74. Singer, N. G., and Caplan, A. I. (2011). Mesenchymal stem cells: mechanisms of inflammation. Annu. Rev. Pathol. 6, 457-478. doi: 10.1146/annurev-pathol-011110-130230.
75. Sovak, M. A., Arsura, M., Zanieski, G., Kavanagh, K. T., and Sonenshein, G. E. (1999). The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression. Cell Growth Differ. 10, 537-544.
76. Tan, C. Y., Lai, R. C., Wong, W., Dan, Y. Y., Lim, S. K., and Ho, H. K. (2014). Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res. Ther. 5, 76. doi: 10.1186/scrt465.
77. Timmers, L., Lim, S. K., Arslan, F., Armstrong, J. S., Hoefer, I. E., Doevendans, P. A., et al. (2008). Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 1, 129-137. doi: 10.1016/j.scr.2008.02.002.
78. Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., and Lötvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659. doi: 10.1038/ncb1596.
79. Vlassov, A. V., Magdaleno, S., Setterquist, R., and Conrad, R. (2012). Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta 1820, 940-948. doi: 10.1016/j.bbagen.2012.03.017.
80. Vrijsen, K., Sluijter, J., Schuchardt, M., Van Balkom, B., Noort, W., Chamuleau, S., et al. (2010). Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. J. Cell. Mol. Med. 14, 1064-1070. doi: 10.1111/j.1582-4934.2010.01081.x.
81. Walter, M., Kohli, N., Major, T., Fuller, H., Wright, K., Kuiper, J., et al. (2015). Human mesenchymal stem cells stimulate EaHy926 endothelial cell migration: combined proteomic and in vitro analysis of the influence of donor-donor variability. J. Stem Cells Regen. Med. 11, 18-24.
82. Wang, M., Zhao, C., Shi, H., Zhang, B., Zhang, L., Zhang, X., et al. (2014). Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer. Br. J. Cancer 110, 1199-1210. doi: 10.1038/bjc.2014.14.
83. Wang, X., Wang, Y., Gou, W., Lu, Q., Peng, J., and Lu, S. (2013). Role of mesenchymal stem cells in bone regeneration and fracture repair: a review. Int. Orthop. 37, 2491-2498. doi: 10.1007/s00264-013-2059-2.
84. Wu, X., Oatley, J. M., Oatley, M. J., Kaucher, A. V., Avarbock, M. R., and Brinster, R. L. (2010). The POU domain transcription factor POU3F1 is an important intrinsic regulator of GDNF-induced survival and self-renewal of mouse spermatogonial stem cells. Biol. Reprod. 82, 1103-1111. doi: 10.1095/biolreprod.109.083097.
85. Xin, H., Li, Y., Buller, B., Katakowski, M., Zhang, Y., Wang, X., et al. (2012). Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30, 1556-1564. doi: 10.1002/stem.1129.
86. Yan, Y., Xu, W., Qian, H., Si, Y., Zhu, W., Cao, H., et al. (2009). Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo. Liver Int. 29, 356-365. doi: 10.1111/j.1478-3231.2008.01855.x.
87. Yang, C., Kim, S.-H., Bianco, N. R., and Robbins, P. D. (2011). Tumor-derived exosomes confer antigen-specific immunosuppression in a murine delayed-type hypersensitivity model. PLoS ONE 6:e22517. doi: 10.1371/journal.pone.0022517.
88. Yang, J., Liu, X. X., Fan, H., Tang, Q., Shou, Z. X., Zuo, D. M., et al. (2015). Extracellular vesicles derived from bone marrow mesenchymal stem cells protect against experimental colitis via attenuating colon inflammation, oxidative stress and apoptosis. PLoS ONE 10:e0140551. doi: 10.1371/journal.pone.0140551.
89. Yoo, J. K., Kim, J., Choi, S. J., Noh, H. M., Kwon, Y. D., Yoo, H., et al. (2011). Discovery and characterization of novel microRNAs during endothelial differentiation of human embryonic stem cells. Stem Cells Dev. 21, 2049-2057. doi: 10.1089/scd.2011.0500.
90. Yu, D. D., Wu, Y., Shen, H. Y., Lv, M. M., Chen, W. X., Zhang, X. H., et al. (2015). Exosomes in development, metastasis and drug resistance of breast cancer. Cancer Sci. 106, 959-964. doi: 10.1111/cas.12715.
91. Yuan, A., Farber, E. L., Rapoport, A. L., Tejada, D., Deniskin, R., Akhmedov, N. B., et al. (2009). Transfer of microRNAs by embryonic stem cell microvesicles. PLoS ONE 4:e4722. doi: 10.1371/journal.pone.0004722.
92. Zhang, B., Wu, X., Zhang, X., Sun, Y., Yan, Y., Shi, H., et al. (2015). Human umbilical cord mesenchymal stem cell exosomes enhance angiogenesis through the Wnt4/beta-catenin pathway. Stem Cells Transl. Med. 4, 513-522. doi: 10.5966/sctm.2014-0267.
93. Zhou, Y., Xu, H., Xu, W., Wang, B., Wu, H., Tao, Y., et al. (2013). Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res. Ther. 4:34. doi: 10.1186/scrt194.
94. Zhu, W., Huang, L., Li, Y., Zhang, X., Gu, J., Yan, Y., et al. (2012). Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Lett. 315, 28-37. doi: 10.1016/j.canlet.2011.10.002.
95. Zomer, H. D., Vidane, A. S., Gonçalves, N. N., and Ambrósio, C. E. (2015). Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives. Stem Cells Cloning 8, 125. doi: 10.2147/SCCAA.S88036.